Novo Nordisk shares dive 9% after heart medicine fails trial

Shares of Novo Nordisk nosedived as much as 10% after the drugmaker said a late-stage heart drug trial failed to reduce major cardiovascular events compared to a placebo. While the experimental medicine, ziltivekimab, did show some biological effect, it didn’t translate into a statistically meaningful reduction in so-called MACE, defined as cardiovascular death, non-fatal heart attack…

Read More

Apple drops 7%, Amazon surges 12% after earnings

Amazon shares surged on Friday while Apple dropped as investors reacted starkly differently to their June quarter earnings reports. Shares of Amazon were 12% higher in premarket trading, while Apple fell 7%. Amazon was nearly 4% higher at Thursday’s close while Apple was down by more than 1%. Both companies reported their June quarter earnings…

Read More